Items where Author is "Aria, H."

Article

(2024) Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development. Heliyon. p. 28.

(2024) Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error. Advanced Biomedical Research. p. 11. ISSN 2277-9175

(2023) Clinical, Laboratory, and Chest CT Features of Dead versus Recovered Coronavirus Disease 2019 (COVID-19) Patients: A Multicenter Study. Journal of Health Sciences and Surveillance System. pp. 186-194. ISSN 23452218 (ISSN)

(2023) Crosstalk between autophagy and insulin resistance: evidence from different tissues. European Journal of Medical Research. p. 26. ISSN 0949-2321

(2023) Current advances in stem cell therapy in the treatment of multiple sclerosis. Reviews in the neurosciences. pp. 613-633. ISSN 2191-0200 (Electronic) 0334-1763 (Linking)

(2023) Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives. Biomedicine & Pharmacotherapy. p. 15. ISSN 0753-3322

(2023) Screening and identification of potential biomarkers for pancreatic cancer: An integrated bioinformatics analysis. Pathology Research and Practice. p. 10. ISSN 0344-0338

(2022) Apelin and its ratio to lipid factors are associated with cardiovascular diseases: A systematic review and meta-analysis. PLOS ONE. e0271899. ISSN 1932-6203

(2022) Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review. ANALYTICAL BIOCHEMISTRY. ISSN 0003-2697 1096-0309 J9 - ANAL BIOCHEM

(2022) Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review. Analytical biochemistry. p. 114546. ISSN 1096-0309 (Electronic) 0003-2697 (Print) 0003-2697 (Linking)

(2022) Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19. LIFE SCIENCES. ISSN 0024-3205 1879-0631 J9 - LIFE SCI

(2022) Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance. Frontiers in Immunology. p. 17. ISSN 1664-3224

(2022) An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy. FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224 J9 - FRONT IMMUNOL

(2021) An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy. Front Immunol. p. 805695. ISSN 1664-3224

(2017) Anxiety but not depression is associated with metabolic syndrome: The Isfahan healthy heart program. Journal of Research in Medical Sciences. ISSN 1735-1995